DECA
Denali Capital Acquisition Corp - Ordinary Shares - Class A

75
Mkt Cap
$1.38B
Volume
100.00
52W High
$23.00
52W Low
$4.50
PE Ratio
-6.33
DECA Fundamentals
Price
$5.00
Prev Close
$5.99
Open
$5.00
50D MA
$7.10
Beta
-0.07
Avg. Volume
25.48
EPS (Annual)
-$0.7833
P/B
-54.44
Rev/Employee
$0.00
$3,087.20
Loading...
Loading...

About

Semnur Pharmaceuticals, Inc. engages in developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. It offers the product, SP-102, a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain. The company was founded in 2013 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 52-week high for Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 52-week low for Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is Semnur Pharmaceuticals Inc - Ordinary Shares - Class A stock price today?
What was Semnur Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
How many employees does Semnur Pharmaceuticals Inc - Ordinary Shares - Class A have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available